BERKLEY W R CORP - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 40 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BERKLEY W R CORP ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q3 2022$1,193,000
+1.4%
119,0470.0%0.06%0.0%
Q2 2022$1,177,000
+0.5%
119,0470.0%0.06%
-3.3%
Q1 2022$1,171,000
+201.0%
119,047
+198.4%
0.06%
+185.7%
Q4 2021$389,00039,8980.02%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q1 2022
NameSharesValueWeighting ↓
Altium Capital Management LP 400,000$3,938,0000.91%
First Trust Capital Management L.P. 167,425$1,648,0000.25%
CVI Holdings, LLC 355,000$3,495,0000.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$1,969,0000.23%
SPHERA FUNDS MANAGEMENT LTD. 329,025$3,239,0000.22%
683 Capital Management, LLC 600,000$5,907,0000.20%
Cowen Investment Management LLC 50,000$492,0000.13%
Shay Capital LLC 74,901$737,0000.08%
Arena Capital Advisors, LLC- CA 100,000$985,0000.08%
EcoR1 Capital, LLC 200,000$1,969,0000.07%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders